FI955829A0 - Heterosyklinen kemia - Google Patents

Heterosyklinen kemia

Info

Publication number
FI955829A0
FI955829A0 FI955829A FI955829A FI955829A0 FI 955829 A0 FI955829 A0 FI 955829A0 FI 955829 A FI955829 A FI 955829A FI 955829 A FI955829 A FI 955829A FI 955829 A0 FI955829 A0 FI 955829A0
Authority
FI
Finland
Prior art keywords
heterocyclic chemistry
hydrogentartrate
thiadiazol
methylpyridine
hexyloxy
Prior art date
Application number
FI955829A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI955829A (fi
Inventor
Linda Marie Osborne
Lisa Ann Shipley
Svend Treppendahl
Torben Guldager Petersen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI955829A0 publication Critical patent/FI955829A0/fi
Publication of FI955829A publication Critical patent/FI955829A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI955829A 1993-06-04 1995-12-04 Heterosyklinen kemia FI955829A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7257293A 1993-06-04 1993-06-04
PCT/DK1994/000205 WO1994029303A1 (fr) 1993-06-04 1994-05-26 Produit chimique heterocyclique

Publications (2)

Publication Number Publication Date
FI955829A0 true FI955829A0 (fi) 1995-12-04
FI955829A FI955829A (fi) 1995-12-04

Family

ID=22108479

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955829A FI955829A (fi) 1993-06-04 1995-12-04 Heterosyklinen kemia

Country Status (22)

Country Link
US (1) US5834495A (fr)
EP (1) EP0703915B1 (fr)
JP (1) JP3190679B2 (fr)
KR (1) KR100339115B1 (fr)
CN (1) CN1064681C (fr)
AT (1) ATE196631T1 (fr)
AU (1) AU698673B2 (fr)
CA (1) CA2164296C (fr)
CZ (1) CZ290550B6 (fr)
DE (1) DE69426021T2 (fr)
DK (1) DK0703915T3 (fr)
ES (1) ES2152315T3 (fr)
FI (1) FI955829A (fr)
GR (1) GR3035033T3 (fr)
HU (1) HUT75038A (fr)
IL (1) IL109866A (fr)
NO (1) NO305560B1 (fr)
NZ (2) NZ267062A (fr)
PT (1) PT703915E (fr)
SK (1) SK281980B6 (fr)
WO (1) WO1994029303A1 (fr)
ZA (1) ZA943904B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117890A (en) * 1996-08-01 2000-09-12 Eli Lilly And Company Method for treating bipolar disorder
US6043258A (en) * 1996-08-01 2000-03-28 Eli Lilly And Company Method for treating disruptive behavior disorders with xanomeline
EP0821954A1 (fr) * 1996-08-01 1998-02-04 Eli Lilly And Company Méthode de traitement d'arriération mentale
EP0821956A1 (fr) * 1996-08-01 1998-02-04 Eli Lilly And Company Méthode de traitement de troubles disruptifs de comportement
US6090829A (en) * 1996-08-01 2000-07-18 Eli Lilly And Company Method for treating excessive aggression
US6034108A (en) * 1997-07-28 2000-03-07 Eli Lilly And Company Method for treating mental retardation
EP3265128A4 (fr) * 2015-03-06 2018-09-12 Chase Pharmaceuticals Corporation Combinaison d'agoniste des récepteurs muscariniques et d'oxybutynine dans un système thérapeutique transdermique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260311A (en) * 1989-02-22 1993-11-09 Novo Nordisk A/S Piperidine compounds and their use
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
US5264444A (en) * 1989-02-22 1993-11-23 Novo Nordisk A/S Piperidine compounds and use

Also Published As

Publication number Publication date
NO954892L (no) 1995-12-01
WO1994029303A1 (fr) 1994-12-22
HUT75038A (en) 1997-03-28
ATE196631T1 (de) 2000-10-15
AU698673B2 (en) 1998-11-05
CZ321095A3 (en) 1996-09-11
NZ336733A (en) 2001-02-23
FI955829A (fi) 1995-12-04
DE69426021T2 (de) 2001-05-17
HU9503453D0 (en) 1996-01-29
ES2152315T3 (es) 2001-02-01
KR100339115B1 (ko) 2002-11-07
SK152095A3 (en) 1996-10-02
CZ290550B6 (cs) 2002-08-14
SK281980B6 (sk) 2001-09-11
DK0703915T3 (da) 2001-01-22
CN1064681C (zh) 2001-04-18
KR960702835A (ko) 1996-05-23
NO305560B1 (no) 1999-06-21
EP0703915A1 (fr) 1996-04-03
ZA943904B (en) 1995-12-04
NO954892D0 (no) 1995-12-01
CA2164296C (fr) 2007-01-23
EP0703915B1 (fr) 2000-09-27
JP3190679B2 (ja) 2001-07-23
AU6924294A (en) 1995-01-03
NZ267062A (en) 1999-09-29
CA2164296A1 (fr) 1994-12-22
PT703915E (pt) 2001-03-30
IL109866A (en) 2000-06-01
JPH08511008A (ja) 1996-11-19
DE69426021D1 (de) 2000-11-02
US5834495A (en) 1998-11-10
IL109866A0 (en) 1994-10-07
CN1128999A (zh) 1996-08-14
GR3035033T3 (en) 2001-03-30

Similar Documents

Publication Publication Date Title
GB9514473D0 (en) Chemical compounds
NO893304D0 (no) Heterocykliske forbindelser.
MY132671A (en) Substituted 6,6-hetero-bicyclic derivatives
KR900700569A (ko) 2,3-디플루오로벤젠 유도체
MX9700696A (es) Compuestos heterociclicos, utiles como productores de efecto aloesterico en receptores muscarinicos.
NZ239514A (en) Oxazole-substituted hydroxy-urea and cyclised hydroxy-urea derivatives, intermediate compounds and medicaments
NO890269L (no) Fremgangsmaate for fremstilling av 1,4-disubstituertepiperidinyl-forbindelser.
FI941776A0 (fi) Menetelmä 1,2,4-tiadiatsolien valmistamiseksi
AU8124791A (en) Halogen-containing compounds, herbicidal composition containing the same as an active ingredient, and intermediary compounds therefor
MY105128A (en) Bu-3608 derivatives.
FI962976A (fi) Viherkaihin hoitoon tarkoitettuja koostumuksia, jotka sisältävät beta-salpaajaa
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
FI955829A0 (fi) Heterosyklinen kemia
HUT50787A (en) Process for producing pharmaceutical compositions comprising 4-aryl-4-piperidine-, pyrrolidine- or hexahydroazepincarbinol derivatives or heterocyclic analogs thereof as active ingredient and process for producing the new compounds
DE59104765D1 (de) Substituierte 5-Alkoxy-1,2,4-triazol-3-(thi)one.
DE69406836D1 (de) Teilweise als Fungizide verwendbare 3,4-Dioxy-1,2,5-thiadiazole
EP0038003A3 (fr) Pyrrolylpipéridines comme antidépresseurs
ATE68486T1 (de) 1-((2-fluorophenyl)(4-fluorophenyl)phenylmethyl - 1h-imidazol.
BR9105402A (pt) Compostos 2,6-alcoxifenil-alquilcetonas e composicoes herbicidas contendo os mesmos
JPS5283836A (en) 2-aminothiazole-4-yl glycine derivatives
OA09328A (en) "Heterocyclic compounds".
DE68910907D1 (de) Fungizide Zusammensetzungen.
AU1512092A (en) Use of 9-amino-1,2,3,4-tetrahydroacridin-1-o1- and related compounds for the treatment of aids
SU1432991A1 (ru) 4-Метил-5-(4-метилфениламино)-1,2,3-триазол, обладающий противовоспалительной активностью
NO894478D0 (no) Heterocykliske derivater av 1,2-difluorbenzen.

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: ELI LILLY AND COMPANY

Free format text: ELI LILLY AND COMPANY

FD Application lapsed